Clinical trial

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors

NCT07071103

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-09-26

PhasePHASE2

Study timeline

Study start (actual)2025-09-26Date precision: day

Registry last updated2025-11-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Radiotherapyunresolved

Metastatic Solid Cancersunresolved

Immune Checkpoint Blockadeunresolved

Esophageal Neoplasms Malignantunresolved

Lung Neoplasm Malignantunresolved

Drug Resistanceunresolved

Interventions

Low-dose radiotherapy to the intestine (ILDR)RADIATION

PD-1/PD-L1 monoclonal antibodiesDRUG

Sponsors & collaborators

Chuangzhen Chenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07071103 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.